Alliance Pharma PLC, a growing consumer healthcare company, is set to release its full-year results for the year ended 31 December 2023 on Tuesday 9 April 2024. The company will hold a meeting for analysts at 9.30 am on the day of the results at Buchanan, 107 Cheapside, London EC2V 6DN. Analysts can register for the meeting by contacting Buchanan at [email protected]. A live webcast of the analyst meeting will be accessible via a provided link, with a recording available on the investor section of Alliance's website following the meeting.
Alliance Pharma PLC, headquartered in the UK, aims to empower people to make a positive difference to their health and wellbeing by making trusted and proven brands available worldwide. The company delivers organic growth through investing in priority brands and channels, related innovation, and selective geographic expansion. With around 285 employees across Europe, North America, and the Asia Pacific region, the Group remains asset-light by outsourcing manufacturing and logistics, focusing on maximizing value for stakeholders and brands.
For further information, interested parties can contact Alliance Pharma PLC or Buchanan, Deutsche Numis, and Investec Bank plc, as listed in the news release. Alliance Pharma PLC's purpose is to empower people to make a positive difference to their health and wellbeing by making trusted and proven brands available around the world. The company delivers organic growth through investing in priority brands and channels, related innovation, and selective geographic expansion. With around 285 employees across Europe, North America, and the Asia Pacific region, the Group remains asset-light by outsourcing manufacturing and logistics, focusing on maximizing value for stakeholders and brands.